title: The SCL +40 enhancer targets the midbrain together with primitive and definitive hematopoiesis and is regulated by SCL and GATA proteins.
abstract: The SCL/Tal-1 gene encodes a basic helix-loop-helix transcription factor with key roles in hematopoietic and neural development. SCL is expressed in, and required for, both primitive and definitive erythropoiesis. Thus far, we have identified only one erythroid SCL enhancer. Located 40 kb downstream of exon 1a, the +40 enhancer displays activity in primitive erythroblasts. We demonstrate here that a 3.7-kb fragment containing this element also targets expression to the midbrain, a known site of endogenous SCL expression. Although the 3.7-kb construct was active in primitive, but not definitive, erythroblasts, a larger 5.0-kb fragment, encompassing the 3.7-kb region, was active in both fetal and adult definitive hematopoietic cells. This included Ter119+ erythroid cells along with fetal liver erythroid and myeloid progenitors. Unlike two other SCL hematopoietic enhancers (+18/19 and -4), +40 enhancer transgenes were inactive in the endothelium. A conserved 400-bp core region, essential for both hematopoietic and midbrain +40 enhancer activity in embryos, relied on two GATA/E-box motifs and was bound in vivo by GATA-1 and SCL in erythroid cells. These results suggest a model in which the SCL +18/19 and/or -4 enhancers initiate SCL expression in early mesodermal derivatives capable of generating blood and endothelium, with subsequent activation of the +40 enhancer via an autoregulatory loop.
authors: Department of Haematology, Cambridge Institute for Medical Research, University of Cambridge, Hills Road, Cambridge CB2 0XY, United Kingdom.
authors: S
authors: S
authors: Ogilvy
authors: R
authors: R
authors: Ferreira
authors: S G
authors: SG
authors: Piltz
authors: J M
authors: JM
authors: Bowen
authors: B
authors: B
authors: Göttgens
authors: A R
authors: AR
authors: Green
mesh_terms: D000818:Animals; D001483:Base Sequence; D051792:Basic Helix-Loop-Helix Proteins / Q000235:genetics / Q000378:metabolism; D001854:Bone Marrow Cells / Q000502:physiology; D004622:Embryo, Mammalian / Q000033:anatomy & histology / Q000502:physiology; D004742:Enhancer Elements, Genetic; D050980:GATA Transcription Factors / Q000235:genetics / Q000378:metabolism*; D006410:Hematopoiesis / Q000502:physiology*; D006801:Humans; D008099:Liver / Q000166:cytology / Q000196:embryology / Q000502:physiology; D008636:Mesencephalon / Q000166:cytology / Q000502:physiology*; D051379:Mice; D008822:Mice, Transgenic; D008969:Molecular Sequence Data; D011518:Proto-Oncogene Proteins / Q000235:genetics / Q000378:metabolism; D016415:Sequence Alignment; D017385:Sequence Homology; D013234:Stem Cells / Q000502:physiology; D000073942:T-Cell Acute Lymphocytic Leukemia Protein 1; D019076:Transgenes
chemical_list: D051792:Basic Helix-Loop-Helix Proteins; D050980:GATA Transcription Factors; D011518:Proto-Oncogene Proteins; D000073942:T-Cell Acute Lymphocytic Leukemia Protein 1; C489366:Tal1 protein, mouse
references: Mol Cell Biol. 2000 Jan;20(2):713-23
references: 10611250
references: Blood. 1999 Dec 1;94(11):3754-63
references: 10572089
references: Blood. 2000 Mar 1;95(5):1652-5
references: 10688820
references: Development. 2001 Dec;128(23):4815-27
references: 11731461
references: EMBO J. 2002 Jun 17;21(12):3039-50
references: 12065417
references: J Biotechnol. 2002 Sep 25;98(2-3):145-60
references: 12141984
references: Nature. 2003 Jan 30;421(6922):547-51
references: 12540851
references: Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):992-7
references: 12552125
references: Mol Cell Biol. 2003 Nov;23(21):7585-99
references: 14560005
references: Neuroscience. 2003;122(2):421-36
references: 14614907
references: Mol Cell Biol. 2004 Feb;24(4):1439-52
references: 14749362
references: Mol Cell Biol. 2004 Mar;24(5):1870-83
references: 14966269
references: Blood. 2004 May 1;103(9):3342-8
references: 14726374
references: EMBO J. 2004 Jul 21;23(14):2841-52
references: 15215894
references: J Immunol. 1973 Jun;110(6):1470-5
references: 4541304
references: Oncogene. 1992 Apr;7(4):653-60
references: 1565464
references: Nature. 1995 Feb 2;373(6513):432-4
references: 7830794
references: Blood. 1995 Aug 15;86(4):1502-14
references: 7632958
references: Cell. 1996 Jul 12;86(1):47-57
references: 8689686
references: EMBO J. 1996 Jul 15;15(14):3713-21
references: 8670875
references: EMBO J. 1996 Aug 15;15(16):4123-9
references: 8861941
references: EMBO J. 1997 Jun 2;16(11):3145-57
references: 9214632
references: Nucleic Acids Res. 1997 Nov 1;25(21):4400-7
references: 9336475
references: Blood. 1998 Jan 15;91(2):419-30
references: 9427694
references: J Biol Chem. 1998 Jun 5;273(23):14347-54
references: 9603943
references: Dev Biol. 1999 May 1;209(1):128-42
references: 10208748
references: Development. 1999 Jun;126(12):2799-811
references: 10331989
references: Dev Biol. 1999 Jun 15;210(2):305-21
references: 10357893
references: Development. 1999 Sep;126(17):3891-904
references: 10433917
references: Blood. 1999 Sep 15;94(6):1855-63
references: 10477714
references: Nucleic Acids Res. 2004;32(21):6454-67
references: 15590906
references: Mol Cell Biol. 2005 Feb;25(4):1215-27
references: 15684376
references: Blood. 2005 May 15;105(10):3871-4
references: 15677556
references: Mol Cell Biol. 2005 Jun;25(12):5215-25
references: 15923636
references: EMBO J. 2005 Jul 6;24(13):2354-66
references: 15920471
references: Int J Dev Neurosci. 2005 Aug;23(5):449-63
references: 16011889
references: Stem Cells. 2005 Oct;23(9):1378-88
references: 16051983
references: Nature. 2005 Nov 17;438(7066):360-3
references: 16292311
references: Eur J Neurosci. 2006 Apr;23(7):1677-89
references: 16623824
references: Blood. 2006 Aug 15;108(4):1251-9
references: 16627757
references: Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):840-5
references: 17213321
references: Nat Biotechnol. 2000 Feb;18(2):181-6
references: 10657125